[1] International Agency for Research on Cancer . Cancer today. https://gco.iarc.fr/today/fact-sheets-populations

[2] National cancer institute . SEER cancer stat facts: cancer of any site. https://seer.cancer.gov/statfacts/html/all.html

[3] Jie HAO. An introduction to oncology(2018).

[4] M PETRÁÑ, M HADRAVSKÝ, M D EGGER et al. Tandem-scanning reflected-light microscope. Journal of the Optical Society of America, 58, 661-664(1968).

[5] J DINNES, J J DEEKS, N CHUCHU et al. Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults. The Cochrane Database of Systematic Reviews, 12, CD013191(2018).

[6] W DENK, J H STRICKLER, W W WEBB. Two-photon laser scanning fluorescence microscopy. Science, 248, 73-76(1990).

[7] Y CHEN, H GUO, W GONG et al. Recent advances in two-photon imaging: technology developments and biomedical applications. Chinese Optics Letters, 11, 011703(2013).

[8] S W HELL, J WICHMANN. Breaking the diffraction resolution limit by stimulated emission: stimulated-emission-depletion fluorescence microscopy. Optics Letters, 19, 780-782(1994).

[9] E BETZIG, G H PATTERSON, R SOUGRAT et al. Imaging intracellular fluorescent proteins at nanometer resolution. Science, 313, 1642-1645(2006).

[10] J BERGSTRAND, L XU, X MIAO et al. Super-resolution microscopy can identify specific protein distribution patterns in platelets incubated with cancer cells. Nanoscale, 11, 10023-10033(2019).

[11] K SAGOLLA, H G LÖHMANNSRÖBEN, C HILLE. Time-resolved fluorescence microscopy for quantitative Ca2+ imaging in living cells. Analytical and Bioanalytical Chemistry, 405, 8525-8537(2013).

[12] A PLISS, X PENG, L LIU et al. Single cell assay for molecular diagnostics and medicine: monitoring intracellular concentrations of macromolecules by two-photon fluorescence lifetime imaging. Theranostics, 5, 919-930(2015).

[13] T VO-DINH. Biomedical photonics handbook(2003).

[14] J R LAKOWICZ. Principles of fluorescence spectroscopy(2006).

[15] Lixin LIU, Junle QU, Ziyang LIN et al. Fluorescence lifetime imaging and its applications in biomedicine. Journal of Shenzhen University, 22, 133-141(2005).

[16] D ELSON, S WEBB, J SIEGEL et al. Biomedical applications of fluorescence lifetime imaging. Optics and Photonics News, 13, 26-56(2002).

[17] R V KRISHNAN, H SAIYOH, H TERADA. Development of a multiphoton fluorescence lifetime imaging microscopy system using a streak camera. Review of Scientific Instruments, 74, 2714-2721(2003).

[18] J QU, L LIU, D CHEN et al. Temporally and spectrally resolved sampling imaging with a specially designed streak camera. Optics letters, 31, 368-370(2006).

[19] Xiongbo LIU, Danying LIN, Qianqian WU et al. The latest research progress of fluorescence lifetime microscopy and its application. Acta Physica Sinica, 67, 27-40(2018).

[20] STOKKUM I H MVAN, D S LARSEN, GRONDELLE RVAN. Global and target analysis of time-resolved spectra. Biochimica et Biophysica Acta, 1657, 82-104(2004).

[21] R DATTA, T M HEASTER, J T SHARICK et al. Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications. Journal of Biomedical Optics, 25, 071203(2020).

[22] Danying LIN, Jingjing NIU, Xiongbo LIU et al. Phasor analysis of fluorescence lifetime data and its application. Acta Physica Sinica, 69, 319-331(2020).

[23] M A DIGMAN, V R CAIOLFA, M ZAMAI et al. The phasor approach to fluorescence lifetime imaging analysis. Biophysical Journal, 94, 14-16(2008).

[24] V MANNAM, Y ZHANG, X YUAN et al. Machine learning for faster and smarter fluorescence lifetime imaging microscopy. Journal of Physics: Photonics, 2, 042005(2020).

[25] J T SMITH, R YAO, N SINSUEBPHON et al. Fast fit-free analysis of fluorescence lifetime imaging via deep learning. Proceedings of the National Academy of Sciences, 116, 24019-24030(2019).

[26] A POLICARD. Étude sur les aspects offerts par des tumeurs expérimentales examinées à la lumière de Wood. Comptes Rendus des Séances de la Société de Biologie et de Ses Filiales, 91, 1423-1424(1924).

[27] W H KOPPENOL, P L BOUNDS, C V DANG. Otto Warburg's contributions to current concepts of cancer metabolism. Nature Reviews Cancer, 11, 325-337(2011).

[28] Buhong LI, Shusen XIE. Application of fluorescence spectroscopy and its imaging technology in optical biopsy. Spectroscopy and Spectral Analysis, 25, 1083-1087(2005).

[29] M NI, S ZHOU. Nonlinear optical microscopy: Endogenous signals and exogenous probes. Annalen der Physik, 527, 471-489(2015).

[30] S B RAYMOND, J SKOCH, I D HILLS et al. Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology. European Journal of Nuclear Medicine and Molecular Imaging, 35, S93-S98(2008).

[31] A THIBON, V C PIERRE. Principles of responsive lanthanide-based luminescent probes for cellular imaging. Analytical & Bioanalytical Chemistry, 394, 107-120(2009).

[32] T NAKABAYASHI, N OHTA. Sensing of intracellular environments by fluorescence lifetime imaging of exogenous fluorophores. Analytical Sciences, 31, 275-285(2015).

[33] L MARCU. Fluorescence lifetime techniques in medical applications. Annals of Biomedical Engineering, 40, 304-331(2012).

[34] L LIU, Q YANG, M ZHANG et al. Fluorescence lifetime imaging microscopy and its applications in skin cancer diagnosis. Journal of Innovative Optical Health Sciences, 12, 1930004(2019).

[35] Hui LI, Xianyuan XIA, Tingai CEHN et al. Applications of two-photon excitation fluorescence lifetime imaging in tumor diagnosis. Chinese Journal of Lasers, 45, 139-152(2018).

[36] National Cancer Institute . SEER Cancer Stat Facts: Brain and Other Nervous System Cancer. https://seer.cancer.gov/statfacts/html/brain.html

[37] Y SUN, N HATAMI, M YEE et al. Fluorescence lifetime imaging microscopy for brain tumor image-guided surgery. Journal of Biomedical Optics, 15, 056022(2010).

[38] S R KANTELHARDT, D KALASAUSKAS, K KÖNIG et al. In vivo multiphoton tomography and fluorescence lifetime imaging of human brain tumor tissue. Journal of Neuro-Oncology, 127, 473-482(2016).

[39] D LIN, T LUO, L LIU et al. Implementation of FLIM and SIFT for improved intraoperative delineation of glioblastoma margin. Chinese Optics of Letters, 15, 20-24(2017).

[40] F POULON, J PALLUD, P VARLET et al. Real-time brain tumor imaging with endogenous fluorophores: a diagnosis proof-of-concept study on fresh human samples. Scientific Reports, 8, 14888(2018).

[41] M V SHIRMANOVA, M LUKINA, E B KISILEVA et al. Interrogation of glioma metabolism on macroscale by FLIM, 10882, 1088209(2019).

[42] A B SCHROEDER, K B POINTER, P A CLARK et al. Metabolic mapping of glioblastoma stem cells reveals NADH fluxes associated with glioblastoma phenotype and survival. Journal of Biomedical Optics, 25, 036502(2020).

[43] National Cancer Institute . SEER cancer stat facts: lung and bronchus cancer. https://seer.cancer.gov/statfacts/html/lungb.html

[44] J S BASUKI, H T T DUONG, A MACMILLAN et al. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano, 7, 10175-10189(2013).

[45] M WANG, F TANG, X PAN et al. Rapid diagnosis and intraoperative margin assessment of human lung cancer with fluorescence lifetime imaging microscopy. BBA Clinical, 8, 7-13(2017).

[46] K AWASTHI, F CHANG, P HSIEH et al. Characterization of endogenous fluorescence in nonsmall lung cancerous cells: a comparison with nonmalignant lung normal cells. Journal of Biophotonics, 13, e201960210(2020).

[47] Minghui CHEN, Hao LI, Rong CHEN et al. A study on the factors influencing auto-fluorescence lifetime of nasopharyngeal tissues in vitro. Acta Laser Biology Sinica, 23, 207-210(2014).

[48] H WANG, S ZHANG, X TIAN et al. High sensitivity of gold nanoparticles co-doped with Gd2O3 mesoporous silica nanocomposite to nasopharyngeal carcinoma cells. Scientific Reports, 6, 34367(2016).

[49] National Cancer Institute . SEER cancer stat facts: oral cavity and pharynx cancer. https://seer.cancer.gov/statfacts/html/oralcav.html

[50] Y SUN, J PHIPPS, D S ELSON et al. Fluorescence lifetime imaging microscopy: in vivo application to diagnosis of oral carcinoma. Optics Letters, 34, 2081-2083(2009).

[51] J A JO, B E APPLEGATE, J PARK et al. In vivo simultaneous morphological and biochemical optical imaging of oral epithelial cancer. IEEE Transactions on Bio-medical Engineering, 57, 2596-2599(2010).

[52] S CHENG. Fluorescence lifetime imaging microscopy (FLIM) system for imaging of oral cancer and precancer(2014).

[53] P PANDE, S SHRESTHA, J PARK et al. Automated analysis of multimodal fluorescence lifetime imaging and optical coherence tomography data for the diagnosis of oral cancer in the hamster cheek pouch model. Biomedical Optics Express, 7, 2000-2015(2016).

[54] B W WEYERS, M MARSDEN, T SUN et al. Fluorescence lifetime imaging for intraoperative cancer delineation in transoral robotic surgery. Translational Biophotonics, 1, 1-16(2019).

[55] E DURAN-SIERRA, S CHENG, R CUENCA-MARTINEZ et al. Clinical label-free biochemical and metabolic fluorescence lifetime endoscopic imaging of precancerous and cancerous oral lesions. Oral Oncology, 105, 104635(2020).

[56] M MARSDEN, B W WEYERS, J BEC et al. Intraoperative margin assessment in oral and oropharyngeal cancer using label-free fluorescence lifetime imaging and machine learning. IEEE transactions on Bio-medical Engineering, 68, 857-868(2020).

[57] National Cancer Institute . SEER cancer stat facts: stomach cancer. https://seer.cancer.gov/statfacts/html/stomach.html

[58] J MCGINTY, N P GALLETLY, C DUNSBY. Wide-field fluorescence lifetime imaging of cancer. Biomedical Optics Express, 1, 14(2010).

[59] X LI, H LI, X HE et al. Spectrum- and time-resolved endogenous multiphoton signals reveal quantitative differentiation of premalignant and malignant gastric mucosa. Biomed Optics Express, 9, 453-471(2018).

[60] National Cancer Institute . SEER cancer stat facts: colorectal cancer. https://seer.cancer.gov/statfacts/html/colorect.html

[61] K T PATE, C STRINGARI, S SPROWL-TANIO et al. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. The EMBO journal, 33, 1-20(2014).

[62] D SUD, W ZHONG, D G BEER et al. Time-resolved optical imaging provides a molecular snapshot of altered metabolic function in living human cancer cell models. Optics Express, 14, 4412-4426(2006).

[63] H WANG, X LIANG, Y H MOHAMMED et al. Real-time histology in liver disease using multiphoton microscopy with fluorescence lifetime imaging. Biomedical Optics Express, 6, 780-792(2015).

[64] National Cancer Institute . SEER cancer stat facts: uterine cancer. https://seer.cancer.gov/statfacts/html/corp.html

[65] Y L WANG, C SONG, M Y WANG et al. Rapid, label-free, and highly sensitive detection of cervical cancer with fluorescence lifetime imaging microscopy. IEEE Journal of Selected Topics in Quantum Electronics, 22, 228-234(2016).

[66] X WANG, Y WANG, Z ZHANG et al. Discriminating different grades of cervical intraepithelial neoplasia based on label-free phasor fluorescence lifetime imaging microscopy. Biomedical Optics Express, 11, 1977-1990(2020).

[67] T NAKAJIMA, K SANO, K SATO et al. Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites. Cancer Science, 105, 308-314(2014).

[68] S SUARASAN, E LICARETE, S ASTILEAN et al. Probing cellular uptake and tracking of differently shaped gelatin-coated gold nanoparticles inside of ovarian cancer cells by two-photon excited photoluminescence analyzed by fluorescence lifetime imaging (FLIM). Colloids and Surfaces B-Biointerfaces, 166, 135-143(2018).

[69] National Cancer Institute . SEER cancer stat facts: prostate cancer. https://seer.cancer.gov/statfacts/html/prost.html

[70] M J O'MELIA, H WALLRABE, Z SVINDRYCH et al. FLIM data analysis of NADH and Tryptophan autofluorescence in prostate cancer cells, 9712, 97122E(2016).

[71] S R ALAM, H WALLRABE, Z SVINDRYCH. Investigation of mitochondrial metabolic response to doxorubicin in prostate cancer cells: an NADH, FAD and tryptophan FLIM assay. Scientific Reports, 7, 10451(2017).

[72] National Cancer Institute . SEER cancer stat facts: bladder cancer. https://seer.cancer.gov/statfacts/html/urinb.html

[73] B PRADÈRE, F POULON, E COMPRAT et al. Two-photon optical imaging, spectral and fluorescence lifetime analysis to discriminate urothelial carcinoma grades. Journal of Biophotonics, 11, e201800065(2018).

[74] R SUAREZ-IBARROLA, L BRAUNB, P F POHLMANNA et al. Metabolic imaging of urothelial carcinoma by simultaneous autofluorescence lifetime imaging (FLIM) of NAD(P)H and FAD. Clinical Genitourinary Cancer, 19, e31-e36(2020).

[75] National Cancer Institute . SEER cancer stat facts: female breast cancer. https://seer.cancer.gov/statfacts/html/breast.html

[76] N P DAMAYANTI, A P CRAIG, J IRUDAYARAJ. A hybrid FLIM-elastic net platform for label free profiling of breast cancer. Analyst, 138, 7127-7134(2013).

[77] J E PHIPPS, D GORPAS, J UNGER et al. Automated detection of breast cancer in resected specimens with fluorescence lifetime imaging. Physics in Medicine and Biology, 63, 1-31(2017).

[78] T ZHOU, T LUO, J SONG et al. Phasor-fluorescence lifetime imaging microscopy analysis to monitor intercellular drug release from a pH-sensitive polymeric nanocarrier. Analytical Chemistry, 90, 2170-2177(2018).

[79] C RIPOLL, M ROLDAN, R CONTRERAS-MONTOYA et al. Mitochondrial pH nanosensors for metabolic profiling of breast cancer cell lines. International Journal of Molecular Sciences, 21, 3731(2020).

[80] National Cancer Institute . SEER cancer stat facts: melanoma of the skin. https://seer.cancer.gov/statfacts/html/melan.html

[81] S SEIDENARI, F ARGINLLI, C DUNSBY et al. Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. PloS One, 8, e70682(2013).

[82] L PIRES, M S NOGUEIRA, S PRATAVIEIRA et al. Time-resolved fluorescence lifetime for cutaneous melanoma detection. Biomedical Optics Express, 5, 3080-3089(2014).

[83] M N PASTORE, H STUDIER, C S BONDER et al. Non-invasive metabolic imaging of melanoma progression. Experimental Dermatology, 26, 607-614(2017).

[84] E MARTÍN-VILLAR, B F MUOZ, M PARSONS et al. Podoplanin associates with CD44 to promote directional cell migration. Molecular Biology of the Cell, 21, 4387-4399(2010).

[85] C R MILLER, M G NICHOLS. Metabolic profiling of the skin to monitor the onset and progression of squamous cell carcinoma through time- and wavelength-resolved fluorescence lifetime imaging. Biophysical Journal, 108, 478A(2015).

[86] J P MILLER, L M HABIMANA-GRIFFIN, T S EDWARDS et al. Multimodal fluorescence molecular imaging for in vivo characterization of skin cancer using endogenous and exogenous fluorophores. Journal of Biomedical Optics, 22, 66007(2017).

[87] R PATALAY, C TALBOT, Y ALEXANDROV et al. Quantification of cellular autofluorescence of human skin using multiphoton tomography and fluorescence lifetime imaging in two spectral detection channels. Biomedical Optics Express, 2, 3295-3308(2011).

[88] S SEIDENARI, F ARGINELLI, C DUNSBY et al. Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics. Experimental Dermatology, 21, 831-836(2012).

[89] T LUO, Y LU, S LIU et al. Phasor-FLIM as a screening tool for the differential diagnosis of actinic keratosis, Bowen's disease, and basal cell carcinoma. Analytical Chemistry, 89, 8104-8111(2017).

[90] B CHEN, Y LU, W PAN et al. Support vector machine classification of nonmelanoma skin lesions based on fluorescence lifetime imaging microscopy. Analytical Chemistry, 91, 10640-10647(2019).

[91] R A ROMANO, R GABRIEL, T ROSA et al. Multispectral autofluorescence lifetime dermoscope for skin lesion assessment. Photodiagnosis and Photodynamic Therapy, 30, 101704(2020).